党参炔苷调控PI3K/AKT通路抑制T-BHP诱导的人髓核细胞铁死亡的机制研究OA
Lobetyolin inhibits T-BHP-induced ferroptosis in human nucleus pulposus cells by regulating PI3K/AKT pathway
基于磷脂酰肌醇 3-激酶(PI3K)/蛋白激酶 B(AKT)通路探讨党参炔苷(LOB)对叔丁基过氧化氢(T-BHP)诱导的人髓核细胞(NPCs)铁死亡的影响,为椎间盘退变的治疗提供理论依据.通过在体外培养人 NPCs,采用 CCK-8 法筛选 T-BHP 诱导造模的最佳浓度及 LOB 的最佳干预浓度.将处于对数生长期的细胞随机分为空白对照组、模型组、Ferrostatin-1(Fer-1)对照组、模型+Fer-1组、PI3K 通路激活剂(740Y-P)组以及 LOB 组.应用 CCK-8法检测各组细胞活力;利用透射电镜观察线粒体超微结构;采用比色法检测细胞内亚铁离子(Fe2+)、丙二醛(MDA)及谷胱甘肽(GSH)水平;采用 Western blot 法检测溶质载体家族 7 成员 11(SLC7A11)、谷胱甘肽过氧化物酶 4(GPX4)、Ⅱ型胶原(collagen Ⅱ)、基质金属蛋白酶-13(MMP-13)、磷酸化磷脂酰肌醇 3-激酶(p-PI3K)及磷酸化蛋白激酶 B(p-AKT)的蛋白表达;通过免疫荧光法检测 p-PI3K 及 p-AKT 的表达水平.结果显示,与空白对照组相比,模型组人 NPCs 活力显著下降,细胞内 Fe2+及脂质过氧化产物 MDA 水平显著升高,抗氧化指标GSH 水平显著降低,蛋白检测显示 SLC7A11、GPX4、collagen Ⅱ表达显著下调,MMP-13 表达显著上调,同时 p-PI3K 及 p-AKT表达水平受到抑制,电镜下可见线粒体皱缩、嵴减少等典型铁死亡形态学改变;与模型组相比,模型+Fer-1 组、740Y-P 组及LOB 组均能显著降低 Fe2+和 MDA 水平,提高 GSH 水平,上调 SLC7A11、GPX4、collagen Ⅱ蛋白表达,并下调 MMP-13 表达.此外,LOB 显著上调人 NPCs 中 p-PI3K 和 p-AKT 的表达水平,且相关指标改善趋势与 740Y-P 组一致.综上,党参炔苷能够有效减轻 T-BHP 诱导的人 NPCs 铁死亡,减少细胞外基质降解,其保护机制可能通过调控 PI3K/AKT 信号通路来实现.
This study aimed to investigate the effect of lobetyolin(LOB)on tert-butyl hydroperoxide(T-BHP)-induced ferroptosis in human nucleus pulposus cells(NPCs)based on the phosphoinositide 3-kinase(PI3K)/protein kinase B(AKT)pathway,thereby providing a theoretical basis for the treatment of intervertebral disc degeneration(IDD).Human NPCs were cultured in vitro.The cell counting kit-8(CCK-8)assay was used to screen the optimal concentration for T-BHP induction and the optimal intervention concentration of LOB.Cells in the logarithmic growth phase were randomly divided into a blank control group,a model group,a Ferrostatin-1(Fer-1)control group,a model+Fer-1 group,a LOB group,and a PI3K/AKT agonist 740Y-P group.Cell viability was assessed using the CCK-8 assay.Intracellular ferrous ion(Fe2+),malondialdehyde(MDA),and glutathione(GSH)levels were measured using colorimetric assays.Mitochondrial ultrastructure was observed using transmission electron microscopy(TEM).The protein expression levels of solute carrier family 7 member 11(SLC7A11),glutathione peroxidase 4(GPX4),collagen type Ⅱ(collagen Ⅱ),matrix metallopeptidase-13(MMP-13),phosphorylated phosphatidylinositol 3-kinase(p-PI3K),and phosphorylated protein kinase B(p-AKT)were determined by Western blot.Additionally,the expression levels of p-PI3K and p-AKT were detected by immunofluorescence.Compared with that in the blank control group,the viability of human NPCs in the model group decreased significantly.Intracellular Fe2+and lipid peroxidation product MDA levels increased significantly,while the antioxidant indicator GSH level decreased significantly in the model group.Protein analysis showed that the expression of SLC7A11,GPX4,and collagen Ⅱ was significantly downregulated,while MMP-13 expression was upregulated.The expression levels of p-PI3K and p-AKT were inhibited.Typical morphological changes of ferroptosis,such as mitochondrial shrinkage and reduction of cristae,were observed under a transmission electron microscope.Compared with the model group,the LOB group,model+Fer-1 group,and 740Y-P group showed significantly reduced levels of Fe2+and MDA,increased GSH levels,upregulated protein expression of SLC7A11,GPX4,and collagenⅡ,and downregulated MMP-13 expression.Furthermore,LOB intervention significantly upregulated the expression levels of p-PI3K and p-AKT in human NPCs,and the improvement trend of related indicators was consistent with that of the 740Y-P group.LOB effectively alleviates T-BHP-induced ferroptosis in human NPCs and reduces extracellular matrix degradation.Its protective mechanism may be achieved by regulating the PI3K/AKT signaling pathway.
徐诗嘉;蒋浩波;李硕夫;李兆勇;陈龙;欧阳文斯;段嘉豪;杨少锋
湖南中医药大学 第一附属医院,湖南 长沙 410007湖南中医药大学 第一附属医院,湖南 长沙 410007湖南中医药大学 第一附属医院,湖南 长沙 410007湖南中医药大学 第一附属医院,湖南 长沙 410007湖南中医药大学 第一附属医院,湖南 长沙 410007湖南中医药大学 第一附属医院,湖南 长沙 410007湖南中医药大学 第一附属医院,湖南 长沙 410007湖南中医药大学 第一附属医院,湖南 长沙 410007
党参炔苷人髓核细胞铁死亡椎间盘退变
lobetyolinhuman nucleus pulposus cellsferroptosisintervertebral disc degeneration
《中国中药杂志》 2026 (7)
1971-1978,8
国家自然科学基金项目(82575113)湖南省自然科学基金项目(S2023JJBMLH1129)湖南中医药大学校级国自然预研课题(2024XJYY04)
评论